澳大利亚的研究者已经开始临床试用一种能阻止人恶性黑素瘤细胞蔓延和生长的抗体。如果试验成功,医生可在数月内开始治疗病人。阿德莱德医学和兽医学研究所的GordonBurns等花了5年时间在实验室试验这种抗体,3周前他们将抗体注入6名病人体内。试验约在6个月后完成。抗体通过阻止皮肤肿瘤内的细胞附着到其他细胞上而使瘤细胞丧失能力。瘤细胞一旦丧失能力,就不会生长或转移 Australian researchers have begun clinical trials of an antibody that can prevent the spread and growth of human melanoma cells. If the test is successful, the doctor can start treating the patient within a few months. Gordon Burns of the Adelaide Institute of Medicine and Veterinary Research spent 5 years testing the antibodies in the lab. They injected antibodies into six patients three weeks ago. The test is completed approximately 6 months later. Antibodies incapacitate neoplastic cells by preventing cells within the skin tumor from attaching to other cells. Once the tumor cells lose their ability, they will not grow or metastasize.